Xeris Pharmaceuticals, Inc.
6 drugs in NADAC|0 Generic,6 Brand
Xeris Pharmaceuticals, Inc. lists 6 NDCs in the CMS NADAC file (0 generic, 6 brand), at an average NADAC of $1869.58 per unit, with a week-over-week move of +0.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
6
0G / 6B
Avg Price / Unit
$1869.5826
$1600.23 – $3203.28
Avg 7d Change
+0.12%
Across 5 drugs with changes
7d Activity
of 6 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does Xeris Pharmaceuticals, Inc. make?
Xeris Pharmaceuticals, Inc. lists 6 NDCs in the CMS NADAC file — 0 generic and 6 brand products.
What is the average price of Xeris Pharmaceuticals, Inc. drugs?
The average NADAC across Xeris Pharmaceuticals, Inc.'s portfolio is $1869.5826 per unit, ranging from $1600.2290 to $3203.2840.
What types of drugs does Xeris Pharmaceuticals, Inc. make?
Xeris Pharmaceuticals, Inc. makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Antihypoglycemic Agent (6), Gastrointestinal Motility Inhibitor (6).
Has Xeris Pharmaceuticals, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Xeris Pharmaceuticals, Inc. in the openFDA feed.
How has Xeris Pharmaceuticals, Inc.'s pricing changed recently?
Over the past 7 days, 4 Xeris Pharmaceuticals, Inc. products rose and 1 fell, with a portfolio-wide average change of +0.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML glucagon injection, solution | $3203.2840 per ML | -0.09% |
GVOKE PFS 2-PK 1 MG/0.2 ML SYR glucagon injection, solution | $1606.1900 per ML | — |
GVOKE HYPOPEN 1-PK 1 MG/0.2 ML glucagon injection, solution | $1603.4599 per ML | +0.03% |
GVOKE HYPOPEN 2-PK 1 MG/0.2 ML glucagon injection, solution | $1603.3466 per ML | +0.39% |
GVOKE 1 MG/0.2 ML KIT glucagon injection, solution | $1600.9864 per ML | +0.18% |
GVOKE PFS 1-PK 1 MG/0.2 ML SYR glucagon injection, solution | $1600.2289 per ML | +0.07% |